1. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA (2004) Disability and quality of life impact of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 420:38–46
2. American Psychiatric Association (APA) (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th edn (text revision). American Psychiatric Association, Washington, DC
3. Angst J (1996) Comorbidity of mood disorders: a longitudinal prospective study. Br J Psychiatry 168:58–67
4. Angst J, Merikangas K (1997) The depressive spectrum: diagnostic classification and course. J Aff Dis 45:31–40
5. Bell RA, Kravitz RL, Wilkes MS (2000) Direct-to-consumer prescription drug advertising, 1989–1998. A content analysis of conditions, targets, inducements, and appeals. J Fam Pract 49:329–335